Telomir Pharmaceuticals (NASDAQ:TELO) Coverage Initiated by Analysts at Rodman & Renshaw
Equities researchers at Rodman & Renshaw began coverage on shares of Telomir Pharmaceuticals (NASDAQ:TELO – Get Free Report) in a research note issued on Friday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Rodman & Renshaw’s target price indicates a potential upside of 283.63% from the […]
Equities researchers at Rodman & Renshaw began coverage on shares of Telomir Pharmaceuticals (NASDAQ:TELO – Get Free Report) in a research note issued on Friday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Rodman & Renshaw’s target price indicates a potential upside of 283.63% from the […]
